Exposure to renin-angiotensin system inhibitors before kidney transplantation is associated with a decreased risk of delayed graft function
Pre-transplant use of ACEi/ARBs is associated with a lower risk of DGF in early postoperative period, which may be due to a protective effect of these agents on renal ischemia-reperfusion injury.
Authors
- Marc Dorais
- Lynne Senécal (ORCID: https://orcid.org/0000-0002-7629-9980)
- Héloïse Cardinal (ORCID: https://orcid.org/0000-0002-9413-651X)
- Majda Belkaid
- Suzon Collette (ORCID: https://orcid.org/0000-0003-0234-4520)
- Gai Liang (ORCID: https://orcid.org/0000-0003-1802-2606)
- Julie Turgeon
Institutions
- University of Alberta (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.3389/fimmu.2024.1447638
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.51
Funders
- Canadian Institutes of Health Research